We demonstrate that there is an interrelationship between EMT signature properties, chemo-resistance inducing factors, and sFRP4 mediated chemo-sensitization in glioma CSCs; thus providing a mode of action of this Wnt antagonist. The gene discussed is SFRP4; the disease is central nervous system cancer.